The Current and Future State of Personalised Medicine
How precision treatments, AI, and genomics are reshaping healthcare by using advanced technologies to deliver tailored treatments, early diagnoses, and better patient outcomes.
Alys Pharmaceuticals Begins Phase IIa Trial for ALY-101 in Alopecia Areata
The pioneering immuno-dermatology company has announced the successful dosing of the first patient in its Phase IIa clinical trial for ALY-101, a novel treatment for Alopecia Areata.
Lifestyle and Environment Matter More Than Genes in Determining Longevity
Recent research has revealed that environmental and lifestyle factors play a far greater role in determining health outcomes and longevity than genetic predisposition, casting light on the age old "nature vs. nurture" debate.